Filippo Torrisi (UNICT-LNS) presso il congresso SIRR2018, 10-13 settembre 2018 (http://www.sirr2.it/sirr2018/) per la presentazione del lavoro "EVALUATION OF NOVEL C-SRC TYROSINE KINASE INHIBITOR AND PROTON THERAPY COMBINED EFFECT: A PRELIMINARY IN VITRO STUDY TOWARD THE PRECLINICAL PHASE FOR GLIOBLASTOMA MULTIFORM E TREATMENT"
Francesco Paolo Cammarata(CNR-LNS) "BREAST CANCER CELLS TREATED WITH PROTON BEAM: IMMUNOLOGICAL FEATURES AND GENE SIGNATURES"